GTN Company
GTN innovates a quantum machine learning technology to transform drug discovery.
Investors
Last Funding Type:
Seed
Technology:
Developing Software
Founded Date:
2017-05-17
Industry:
Application Software
Funding Status:
Seed
Headquarters:
London, England, United Kingdom
Estimated Revenue:
$1M to $10M
Employee Number:
1-10
Last Funding Date:
2018-11-01
Total Funding:
2100000.0
Investors Number:
6.0